NewEdge Advisors’s Trueblue TBI Stock Holding History

NewEdge Advisors’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50	Closed	-$626	–	3993
2024 Q1	$626	Hold	50	–	–	﹤0.01%	3561
2023 Q4	$767	Buy	+50	New	+$699	﹤0.01%	3496

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NewEdge Advisors's TBI Position: Q2 2024 in Review

NewEdge Advisors sold out of Trueblue (TBI) in Q2 2024, closing a stake of 50 shares — an estimated $626 sold.

NewEdge Advisors first reported a position in TBI in Q4 2023 and held it in 2 quarters. The position peaked at $767 in Q4 2023. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

NewEdge Advisors reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
NewEdge Advisors sold 50 Trueblue shares in Q2 2024, an estimated $626.
NewEdge Advisors first reported a position in Trueblue in Q4 2023 and held it in 2 quarters.
NewEdge Advisors's Trueblue position peaked at $767 in Q4 2023.
121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.